Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
Expert Review of Hematology|June 24, 2022
Recent advances in therapeutic options for rare hemostatic disorders: selected poster extracts of recent research in hemophilia A, congenital hemophilia with inhibitors, von Willebrand disease, and thrombotic thrombocytopenic purpura presented at the 29th congress of the International Society on Thrombosis and Haemostasis (ISTH 2021, Jul 17-21; virtual congress)Nisha Jain, Johannes Oldenburg, Margareth C Ozelo, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2022
Haemophilia gene therapy-Update on new country initiativesUlrike M Reiss, Johnny Mahlangu, Tsukasa Ohmori, et al.Blood Reviews|November 22, 2025
Long-term durability of rAAV gene therapy in hemophilia: Factor expression, clinical outcomes and underlying molecular mechanismsYesim Dargaud, Gabriela G Yamaguti-Hayakawa, Jéssica O Frade-Guanaes, et al.Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Immunogenicity of Current and New Therapies for Hemophilia AAlessandra N L Prezotti, Jéssica O Frade-Guanaes, Gabriela G Yamaguti-Hayakawa, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2021
Aquatic exercise in patients with haemophilia: Electromyographic and functional results from a prospective cohort studyGlenda Feldberg, Janaína B S Ricciardi, Alessandro R Zorzi, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|March 25, 2024
Promoting pain coping skills in haemophilia: A remote intervention integrating exercise and pain educationGlenda Feldberg, Janaína B S Ricciardi, Alessandro R Zorzi, et al.Research and Practice in Thrombosis and Haemostasis|September 11, 2023
Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasisAmy D Shapiro, Hervé Chambost, Margareth C Ozelo, et al.Hematology Reports|July 4, 2017
Thalidomide for the Treatment of Gastrointestinal Bleeding Due to Angiodysplasia in a Patient with Glanzmann's ThrombastheniaBruno K L Duarte, Sílvia M de Souza, Carolina Costa-Lima, et al.Expert Review of Hematology|August 9, 2021
Addressing unmet needs in rare bleeding disorders: selected poster extracts of recent research in hemophilia A and von Willebrand disease presented at the 14th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) (Feb 3-5, 2021; virtual congress)Geoffrey Allen, Ping Du, Kate Khair, et al.Therapeutic Advances in Hematology|February 19, 2024
The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international studyMargareth C Ozelo, Cedric Hermans, Manuel Carcao, et al.Pageof 7